Skip to content
Search

Latest Stories

Pharmacies were 'heroes of the pandemic' says NPA as Covid hearings resume

Pharmacies were 'heroes of the pandemic' says NPA as Covid hearings resume

“Pharmacies deserve huge recognition for their phenomenal work during the Covid-19 pandemic

The National Pharmacy Association (NPA) has hailed pharmacies as “heroes of the Covid-19 pandemic,” as it prepared to make its opening statement at the UK Covid-19 Inquiry's Module 3, which begins public hearings this week.


The NPA's legal team will deliver a statement to the inquiry team at the start of 10 weeks of formal sessions, focusing on the impact of the pandemic on healthcare systems in the UK.

Paul Rees, Chief Executive of the NPA, emphasised the critical role pharmacies played during the crisis.

He said: “Pharmacies up and down the land were heroes of the pandemic and deserve huge recognition for their phenomenal work staying open when so much of the health system was forced to close and then delivering life-saving vaccinations to millions of people.

“Pharmacies – as they always have - stepped up in the country’s hour of need, despite crippling underfunding and neglect over more than a decade that continues to this day.

“We are taking part in the Covid inquiry to tell that story of dedication, sacrifice and service, and to remind policymakers today that they need to nurture and respect the pharmacy network so it is there and ready should any future health emergency hit our shores.”

The NPA has been designated as a core participant in Modules 3 (impact on healthcare systems) and 4 (vaccines and therapeutics) of the Inquiry proceedings.

It previously presented preliminary evidence during the Module 3 hearing on April 10, 2024, underscoring the challenges community pharmacies faced in responding to the pandemic due to long-term underinvestment.

Deirdre Domingo, the NPA's legal representative told the Inquiry: “Community pharmacy entered the pandemic facing financial and workforce crises, due to long term underinvestment in the network.

“These issues presented significant challenges for community pharmacy in responding to the pandemic and increased the difficulties in providing services to patients and maintaining staffing levels.

“Even though the pandemic clearly showed that pharmacies are an essential part of health and social care, real-term funding cuts have continued, and the independent community pharmacy sector finds itself in a worse situation than at the outset of the pandemic with pharmacies closing at the rate of approximately eight per week.”

During the Module 4 preliminary hearing on May 22, the NPA highlighted that community pharmacies should have been involved earlier in planning the COVID vaccination programme.

Lawyer Brian Stanton, speaking on behalf of the NPA, told the Inquiry: “Community pharmacy was initially given a gap in service role, which failed to fully utilize their experience, expertise and resource.”

The UK Covid-19 Inquiry, which began on June 28, 2022, is examining the nation's response to and impact of the pandemic to learn lessons for the future.

The investigations are divided into various modules, with the first report published on July 18, 2024.

Baroness Heather Hallett, Chair of the Inquiry, outlined 10 recommendations in the Module 1 report and urged the UK government, as well as the governments of Wales, Scotland, and Northern Ireland, to implement them promptly.

Key recommendations include radically simplifying civil emergency preparedness and resilience systems, holding a UK-wide pandemic response exercise every three years, and establishing a single, independent statutory body responsible for system-wide preparedness and response.

More For You

13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less
 Government launches call for evidence on England’s first ever men’s health strategy

Wes Streeting

Pic credit: Getty images

Call for Evidence: Streeting urges public to help shape men’s health strategy

The government is urging men of all ages to come forward and contribute to the development of England’s first-ever men’s health strategy, a key initiative under its Plan for Change.

On Thursday (24), the Department of Health and Social Care (DHSC) launched a 12-week call for evidence, seeking insights from the public, health and social care professionals, academics and employers on ways to prevent and tackle the biggest issues facing men.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less